Epstein-Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer that is highly treatable when diagnosed early, with 5-year disease-free survival of approximately 90%. However, NPC is typically diagnosed at advanced stages, in which disease-free survival is

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2014-07, Vol.23 (7), p.1213-1219
Hauptverfasser: COGHILL, Anna E, HSU, Wan-Lun, HILDESHEIM, Allan, PFEIFFER, Ruth M, JUWANA, Hedy, YU, Kelly J, LOU, Pei-Jen, WANG, Cheng-Ping, CHEN, Jen-Yang, CHEN, Chien-Jen, MIDDELDORP, Jaap M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer that is highly treatable when diagnosed early, with 5-year disease-free survival of approximately 90%. However, NPC is typically diagnosed at advanced stages, in which disease-free survival is
ISSN:1055-9965
1538-7755
DOI:10.1158/1055-9965.epi-13-1262